(Nitrendipine)
Nitrendipine, the active substance of Nitresan 20 mg, belongs to a group of medicines called calcium antagonists. It helps to reduce tension and widen blood vessels. As the blood vessels are widened, blood pressure is lowered. The doctor will prescribe the tablets to reduce high blood pressure.
Before starting to take Nitresan 20 mg, discuss it with your doctor or pharmacist:
During treatment with Nitresan 20 mg, regular medical check-ups are necessary.
The medicine is not indicated for use in children and adolescents.
Tell your doctor or pharmacist about all medicines you are taking now or have taken recently, as well as about medicines you plan to take. The following medicines or groups of medicines may affect the action of Nitresan 20 mg:
When taking Nitresan 20 mg with any of the above-mentioned medicines, the doctor should closely monitor blood pressure and, if necessary, adjust the treatment.
Grapefruit juice inhibits the metabolism of nitrendipine. Therefore, during treatment with Nitresan 20 mg, do not consume grapefruit juice.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. The use of Nitresan 20 mg during pregnancy is contraindicated. Experimental studies with nitrendipine have shown developmental disorders in the fetus. Data on the use of the medicine in pregnant women are insufficient. Nitrendipine passes into human milk in small amounts. The effect of nitrendipine on newborns and breastfed children is unknown. Nitrendipine may affect fertility in men. In men who have repeatedly and unsuccessfully tried to become fathers through fertilization procedures, the use of nitrendipine should be considered as a possible cause of failure. If pregnancy is planned, alternative treatment should be considered.
During treatment for high blood pressure, the patient should be under control. Treatment for high blood pressure may affect the ability to drive vehicles and operate machinery. This is especially likely at the beginning of treatment, when increasing the dose, when changing the medicine, or when consuming alcohol at the same time.
If you have been diagnosed with an intolerance to some sugars, contact your doctor before taking the medicine.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is considered "sodium-free".
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist. Since the medicine is sensitive to light, the tablets should be stored in the original packaging (see also section 5). The recommended dose for adults is 1 tablet of Nitresan 20 mg in the morning (corresponding to 20 mg of nitrendipine per day). If the reduction in blood pressure is not satisfactory, the daily dose can be increased to 1 tablet twice a day (corresponding to 40 mg of nitrendipine per day). The maximum daily dose of nitrendipine is 40 mg. The tablets should be taken after a meal (in the morning and evening), with a sufficient amount of liquid. Do not take the tablets with grapefruit juice, as Nitresan 20 mg may then work too strongly. Treatment for high blood pressure is long-term. The doctor will inform you how long you should take the medicine. Use in children and adolescentsNitresan 20 mg is not indicated for use in children and adolescents due to a lack of sufficient experience with the use of the medicine in this age group. Patient with impaired liver functionPatients with impaired liver function may be more sensitive to the effect of Nitresan 20 mg. The doctor will recommend the smallest dose that allows control of blood pressure. Patient with impaired kidney functionThere is no need to adjust the dose in patients with impaired kidney function. Elderly patientsThe doctor will recommend the smallest effective dose and will monitor the patient's condition.
Symptoms of acute overdose are: sudden flushing, headache, decreased blood pressure (with circulatory collapse), and changes in heart rate (fast or slow pulse). In case of overdose, consult a doctor.
Do not take a double dose to make up for a forgotten dose. Take the next tablet at the normal time.
If you want to stop taking the medicine, e.g., due to side effects, consult your doctor first. Do not stop treatment without your doctor's advice. If you have any further questions about the use of this medicine, ask your doctor.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Common(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
If you experience any side effects, including those not listed in this package leaflet, please inform your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309, website: https://smz.ezdrowie.gov.pl Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children. Do not store above 25°C. Store in the original packaging to protect from light. Do not use this medicine after the expiry date stated on the packaging after "EXP". The expiry date refers to the last day of the month. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substance is nitrendipine. Each tablet contains 20 mg of nitrendipine. The other ingredients are: lactose monohydrate, corn starch, microcrystalline cellulose, povidone K-25, sodium docusate, magnesium stearate.
Yellow, flat tablets with a dividing line on one side and a strength marking on the other side, 7 mm in diameter. The dividing line is not intended for breaking the tablet. Pack sizes: 20, 30, 50, 60, or 100 tablets. Not all pack sizes may be marketed.
PRO.MED. CS. Praha a.s., Telčská 377/1, Michle, 140 00 Praha 4, Czech Republic
Germany: Nitresan 20 mg Tablets Estonia: Nitresan 20 mg Lithuania: Nitresan 20 mg Latvia: Nitresan 20 mg Poland: Nitresan 20 mg Slovakia: NITRESAN 20 mg Czech Republic: Nitresan Date of last revision of the package leaflet:20.08.2021
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.